recent guidelines affirm its use (e.g., AHA updates, StatPearls reviews)
Most studies, systematic reviews, and meta-analyses which examined the validity of -synuclein in the CSF as a putative biomarker for PD emphasized that a decreased level of -synuclein in CSF reliably separated PD from control subjects, but the specificity of this measurement was low (Mollenhauer et al., 2011, 2013
doi: 10.3390/antiox12081577
Environmental pollutants, UV radiation, and poor diet all contribute to this burden
Hasegawa M, Takahashi H, Rajabi H, Alam M, Suzuki Y, Yin L, et al
Cognitive decline, brain fog, fatigue, post-viral dysfunction, and mild memory issues